Today's report also covers dactylitis in active psoriatic arthritis patients, risankizumab use, and more (1,900 words, 9 minutes, 30 seconds)
Efficacy and safety of deucravacitinib in Japanese patients with moderate to severe plaque psoriasis
Efficacy and safety of deucravacitinib in…
Today's report also covers dactylitis in active psoriatic arthritis patients, risankizumab use, and more (1,900 words, 9 minutes, 30 seconds)